Developed in collaboration with Avicenna.AI, the newly FDA-cleared technology introduces UPTUNITY™, Bracco's new portfolio of AI-enabled clinical decision support solutions. MILAN, Nov. 13, 2026 /PRNewswire/ -- Bracco and Avicenna.AI today announced U.S. Food and Drug Administration (FDA)...
Hence then, the article about bracco and avicenna ai announce fda clearance for uptunity aneurysm a new ai enabled software for brain aneurysm detection and assessment was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Bracco and Avicenna.AI Announce FDA Clearance for UPTUNITY™ .. Aneurysm, a New AI-Enabled Software for Brain Aneurysm Detection and Assessment )
Also on site :
- DeFi Technologies Inc. Announces Third Quarter 2026 Financial Results with Revenue of $18.3 Million, Operating Income of $7.0 Million, and Net Income of $22.3 Million
- Venezuela Ends 19-Year Power Monopoly, With Oil Fields First in Line
- ‘Bring Back THE Boss’: Nvidia Employees Petition for Jensen Huang’s Return